MCID: HRT032
MIFTS: 75

Heart Disease malady

Categories: Cardiovascular diseases, Genetic diseases

Aliases & Classifications for Heart Disease

Aliases & Descriptions for Heart Disease:

Name: Heart Disease 12 3 14
Congenital Heart Disease 12 52 14 69
Congenital Heart Defects 12 41 3 14
Heart Diseases 52 41 42 69
Heart Failure 52 41 69
Heart-Congenital Defect 12 29
Heart Defect 12 29
Congenital Anomaly of Heart 12
Heart Defects, Congenital 42
Congestive Heart Failure 69
Heart Defects Congenital 52
Congenital Heart Defect 12
Heart Malformation 12

Classifications:



Summaries for Heart Disease

MedlinePlus : 41 if you're like most people, you think that heart disease is a problem for others. but heart disease is the number one killer in the u.s. it is also a major cause of disability. there are many different forms of heart disease. the most common cause of heart disease is narrowing or blockage of the coronary arteries, the blood vessels that supply blood to the heart itself. this is called coronary artery disease and happens slowly over time. it's the major reason people have heart attacks. other kinds of heart problems may happen to the valves in the heart, or the heart may not pump well and cause heart failure. some people are born with heart disease. you can help reduce your risk of heart disease by taking steps to control factors that put you at greater risk: control your blood pressure lower your cholesterol don't smoke get enough exercise nih: national heart, lung, and blood institute

MalaCards based summary : Heart Disease, also known as congenital heart disease, is related to sick sinus syndrome 1 and arrhythmogenic right ventricular dysplasia 2, and has symptoms including hypoplastic left heart, angina pectoris and chest pain. An important gene associated with Heart Disease is TBX5 (T-Box 5), and among its related pathways/superpathways are Cardiac conduction and Vascular smooth muscle contraction. The drugs Iloprost and Bupivacaine have been mentioned in the context of this disorder. Affiliated tissues include heart, endothelial and lung, and related phenotypes are cardiovascular system and growth/size/body region

Disease Ontology : 12 A cardiovascular system disease that involves the heart.

CDC : 3 In the United States, the most common type of heart disease is coronary artery disease (CAD), which can lead to heart attack. You can greatly reduce your risk for CAD through lifestyle changes and, in some cases, medication. Learn more about heart disease.

Related Diseases for Heart Disease

Diseases in the Heart Disease family:

Congenital Heart Defects, Nonsyndromic, 2 Congenital Heart Defects, Multiple Types, 3
Congenital Heart Defects, Multiple Types, 4

Diseases related to Heart Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 837)
id Related Disease Score Top Affiliating Genes
1 sick sinus syndrome 1 31.5 RYR2 SCN5A TNNT2
2 arrhythmogenic right ventricular dysplasia 2 31.5 RYR2 SCN5A
3 hypertension, essential 30.9 ACE ADRB1 EDN1 NPPA NPPB REN
4 myocardial infarction 30.8 ACE ADRB1 EDN1 GATA4 GJA1 NPPA
5 lupus erythematosus 30.2 ACE TNNI3 TNNT2
6 third-degree atrioventricular block 29.8 GATA4 NKX2-5 NPPB SCN5A TBX5
7 pericardium disease 29.7 MYH7 NKX2-5 NPPB ZIC3
8 myopia 29.5 ACE EDN1 NPPA REN
9 pyelonephritis 29.4 ACE EDN1 NPPA NPPB REN
10 long qt syndrome 9 29.3 ACE MYH7 NPPB PTPN11 RYR2 TNNI3
11 hypertensive heart disease 12.2
12 conotruncal heart malformations 12.2
13 rheumatic heart disease 12.0
14 ischemic heart disease 12.0
15 critical congenital heart disease 12.0
16 testicular anomalies with or without congenital heart disease 11.9
17 coronary heart disease 5 11.9
18 kyphoscoliotic heart disease 11.9
19 coronary heart disease 6 11.9
20 coronary heart disease 7 11.9
21 chronic pulmonary heart disease 11.9
22 cleft-limb-heart malformation syndrome 11.8
23 cfc1-related conotruncal heart malformations 11.8
24 coronary artery disease 11.7
25 acute pulmonary heart disease 11.7
26 craniostenosis, sagittal, with congenital heart disease, mental deficiency, and mandibular ankylosis 11.7
27 hirschsprung disease polydactyly heart disease 11.7
28 coronary heart disease 9 11.7
29 shoulder and thorax deformity congenital heart disease 11.7
30 isolated nonsyndromic congenital heart disease/defects 11.7
31 craniofacial abnormalities, cataracts, congenital heart disease, sacral neural tube defects, and growth and developmental retardation 11.7
32 coronary heart disease 8 11.7
33 coronary heart disease 4 11.7
34 coronary heart disease 3 11.7
35 coronary heart disease 2 11.7
36 microcephaly, congenital heart disease, unilateral renal agenesis, and hyposegmented lungs 11.7
37 congenital heart disease, atrial septal defect 11.6
38 short limbs abnormal face congenital heart disease 11.6
39 down syndrome-related congenital heart disease 11.6
40 kallmann syndrome-heart disease syndrome 11.6
41 craniostenosis with congenital heart disease mental retardation 11.6
42 short stature valvular heart disease 11.6
43 microcephaly-seizures-intellectual disability-heart disease syndrome 11.6
44 cleft palate heart disease polydactyly absent tibia 11.6
45 congenital heart disease ptosis hypodontia craniostosis 11.6
46 brain malformation-congenital heart disease-postaxial polydactyly syndrome 11.6
47 congenital heart disease radio ulnar synostosis mental retardation 11.6
48 polyvalvular heart disease syndrome 11.6
49 cleft lip/palate with characteristic facies, intestinal malrotation, and lethal congenital heart disease 11.6
50 congestive heart failure 11.6

Comorbidity relations with Heart Disease via Phenotypic Disease Network (PDN): (show top 50) (show all 319)


Abdominal Obesity-Metabolic Syndrome 1 Accessory Nerve Disease
Acquired Polycythemia Acquired Thrombocytopenia
Active Peptic Ulcer Disease Acute Anterolateral Myocardial Infarction
Acute Apical Periodontitis Acute Conjunctivitis
Acute Cor Pulmonale Acute Cystitis
Acute Inferolateral Myocardial Infarction Acute Kidney Failure
Acute Maxillary Sinusitis Acute Myocardial Infarction
Acute Myocarditis Acute Pancreatitis
Adjustment Disorder Adrenal Cortical Hypofunction
Alcoholic Cardiomyopathy Alcoholic Liver Cirrhosis
Allergic Urticaria Alzheimer Disease
Amyloidosis Anthracosis
Anxiety Disorder Aortic Aneurysm
Aortic Atherosclerosis Aortic Valve Disease 2
Aortic Valve Insufficiency Aplastic Anemia
Asbestosis Aspergillosis
Asthma Asthma, Phf11-Related
Atrioventricular Block Atrophic Gastritis
Autoimmune Hemolytic Anemia Bacteremia
Balanoposthitis Basilar Artery Insufficiency
Benign Essential Hypertension Benign Hypertensive Renal Disease
Benign Renovascular Hypertension Bleeding Disorder, Platelet-Type, 11
Blepharitis Blepharoconjunctivitis
Bronchiectasis Bronchitis
Bronchopneumonia Budd-Chiari Syndrome

Graphical network of the top 20 diseases related to Heart Disease:



Diseases related to Heart Disease

Symptoms & Phenotypes for Heart Disease

Human phenotypes related to Heart Disease:

32
id Description HPO Frequency HPO Source Accession
1 hypoplastic left heart 32 HP:0004383

UMLS symptoms related to Heart Disease:


angina pectoris, chest pain, edema, tremor, equilibration disorder, syncope

MGI Mouse Phenotypes related to Heart Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.34 ACE ADRB1 EDN1 GATA4 GJA1 MYH7
2 growth/size/body region MP:0005378 10.21 ACE ADRB1 EDN1 GATA4 WRB ZIC3
3 embryo MP:0005380 10.14 TBX5 TNNT2 WRB ZIC3 EDN1 GATA4
4 mortality/aging MP:0010768 10.13 ACE ADRB1 EDN1 GATA4 GJA1 NKX2-5
5 homeostasis/metabolism MP:0005376 10.1 TNNT2 ACE ADRB1 EDN1 GATA4 GJA1
6 muscle MP:0005369 10 REN RYR2 SCN5A TBX5 TNNI3 TNNT2
7 no phenotypic analysis MP:0003012 9.5 ADRB1 GATA4 GJA1 MYH7 NKX2-5 PTPN11
8 normal MP:0002873 9.36 EDN1 GATA4 GJA1 NKX2-5 PTPN11 REN

Drugs & Therapeutics for Heart Disease

Drugs for Heart Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1357)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Iloprost Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 78919-13-8 6443959
2
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 2180-92-9, 38396-39-3 2474
3
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 51-43-4 5816
4
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
5
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Phase 1 103-90-2 1983
6
Ibuprofen Approved Phase 4,Phase 3,Phase 2,Phase 1 15687-27-1 3672
7
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
8
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-78-2 2244
9
Ticlopidine Approved Phase 4,Phase 2,Phase 3 55142-85-3 5472
10
Clozapine Approved Phase 4 5786-21-0 2818
11 Moxonidine Approved Phase 4,Phase 3 75438-57-2 4810
12
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
13
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 657-24-9 14219 4091
14
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-61-7 60961
15
Dipyridamole Approved Phase 4,Phase 3,Phase 2 58-32-2 3108
16
Regadenoson Approved Phase 4,Phase 2,Phase 1,Early Phase 1 313348-27-5 219024
17
Ephedrine Approved Phase 4,Phase 2,Phase 1 299-42-3 9294
18
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-41-2 439260
19
Oxymetazoline Approved Phase 4,Phase 3,Phase 2,Phase 1 1491-59-4 4636
20
Phenylephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 59-42-7 6041
21
Pseudoephedrine Approved Phase 4,Phase 2,Phase 1 90-82-4 7028
22
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2216-51-5 16666
23
Ranolazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 142387-99-3, 95635-55-5 56959
24
Cilostazol Approved Phase 4 73963-72-1 2754
25
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
26
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
27
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
28
Fluvastatin Approved Phase 4,Phase 3,Phase 2 93957-54-1 1548972
29
Carvedilol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 72956-09-3 2585
30
Clonidine Approved Phase 4,Phase 2,Early Phase 1 4205-90-7 2803
31
Dobutamine Approved Phase 4,Phase 2,Phase 3,Phase 1 34368-04-2 36811
32
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 33069-62-4 36314
33
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
34
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 10102-43-9 145068
35
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6 772 46507594
36
Nicorandil Approved Phase 4 65141-46-0 47528
37
Acarbose Approved, Investigational Phase 4,Phase 3,Phase 1 56180-94-0 441184
38
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 137862-53-4 60846
39
Verapamil Approved Phase 4,Phase 3,Phase 2,Phase 1 52-53-9 2520
40
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
41
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 7440-66-6 32051 23994
42
Methyltestosterone Approved Phase 4,Phase 3,Phase 2,Phase 1 58-18-4 6010
43
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 58-22-0 6013
44
Amiodarone Approved, Investigational Phase 4,Phase 3,Phase 2 1951-25-3 2157
45
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
46
Esomeprazole Approved, Investigational Phase 4,Phase 2 161796-78-7, 119141-88-7 4594 9579578
47
Pantoprazole Approved Phase 4,Phase 3 102625-70-7 4679
48
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
49
Citalopram Approved Phase 4 59729-33-8 2771
50
Ezetimibe Approved Phase 4,Phase 3,Phase 2,Phase 1 163222-33-1 150311

Interventional clinical trials:

(show top 50) (show all 9989)
id Name Status NCT ID Phase
1 Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist Unknown status NCT00668824 Phase 4
2 Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease Unknown status NCT01383083 Phase 4
3 Comparison of the Local Anaesthetics Articaine and Bupivacaine in Treatment of Acute Sternum Pain After Heart Surgery Unknown status NCT01536717 Phase 4
4 Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease Unknown status NCT00188188 Phase 4
5 Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants Unknown status NCT01544972 Phase 4
6 Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD Unknown status NCT02008786 Phase 4
7 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Unknown status NCT00166257 Phase 4
8 Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO) Unknown status NCT01550588 Phase 4
9 Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects Unknown status NCT00799045 Phase 4
10 Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure Unknown status NCT01156207 Phase 4
11 Alleviating the Metabolic Side Effects of Antipsychotic Medications Unknown status NCT01567124 Phase 4
12 Diagnostic Benefits of HyperQTM vs. Conventional ECG Stress Test. Comparison of HyperQ vs. Stress ECG in Women Before Angiography Unknown status NCT00850486 Phase 4
13 Cardiovascular Effects of Metformin on Obesity Unknown status NCT01910246 Phase 4
14 Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress Unknown status NCT00808314 Phase 4
15 Rationale, Design and Methods for the Early Surgery in Infective Endocarditis Study (ENDOVAL) Unknown status NCT00624091 Phase 4
16 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4
17 A Pilot Trial of Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients Unknown status NCT02203630 Phase 4
18 Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer Unknown status NCT00628784 Phase 4
19 Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function Unknown status NCT01825759 Phase 4
20 Ranolazine for Improving Symptoms of Palpitations Unknown status NCT01495520 Phase 4
21 Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen Unknown status NCT01267734 Phase 4
22 Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease Unknown status NCT00917527 Phase 4
23 Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease Unknown status NCT01768585 Phase 4
24 Fluvastatin AmelIorates aTHerosclerosis Study Unknown status NCT01681199 Phase 4
25 Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization Unknown status NCT01342822 Phase 4
26 Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Unknown status NCT01382277 Phase 4
27 Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery Unknown status NCT01457586 Phase 4
28 Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol Unknown status NCT01425164 Phase 4
29 EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine) Unknown status NCT00335582 Phase 4
30 Study of Effects of Sildenafil on Patients With Fontan Heart Circulation Unknown status NCT01815502 Phase 4
31 Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT Unknown status NCT01021930 Phase 4
32 Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing Unknown status NCT01456364 Phase 4
33 Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents Unknown status NCT01068106 Phase 4
34 Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES) Unknown status NCT01942044 Phase 4
35 Intracoronary Stenting and Angiographic Results: ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography Unknown status NCT01594736 Phase 4
36 Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography Unknown status NCT01260558 Phase 4
37 Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography Unknown status NCT01230723 Phase 4
38 Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study Unknown status NCT01064323 Phase 4
39 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4
40 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4
41 Enteral Nutrition After Cardiovascular Surgery Unknown status NCT01432769 Phase 4
42 The ABC Trial Does All-Blood Cardioplegia Prevent Blood Transfusion in Cardiac Surgery? A Single Centre Pilot Study Unknown status NCT01623193 Phase 4
43 Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction Unknown status NCT00888758 Phase 4
44 Revascularization in Heart Failure Trial – REHEAT 2 Unknown status NCT00388245 Phase 4
45 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4
46 Effect of Ranolazine on Valvular Disease in Patients With Pacemakers Unknown status NCT01979965 Phase 4
47 Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy Unknown status NCT00348530 Phase 4
48 Metformin in Postmenopausal Women With Metabolic Syndrome Unknown status NCT01342744 Phase 4
49 Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients Unknown status NCT00155350 Phase 4
50 Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP Unknown status NCT00584350 Phase 4

Search NIH Clinical Center for Heart Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: heart diseases

Genetic Tests for Heart Disease

Genetic tests related to Heart Disease:

id Genetic test Affiliating Genes
1 Congenital Heart Disease 29
2 Congenital Heart Defects 29
3 Heart Disease 29

Anatomical Context for Heart Disease

MalaCards organs/tissues related to Heart Disease:

39
Heart, Endothelial, Lung, Testes, Brain, Bone, Breast

Publications for Heart Disease

Articles related to Heart Disease:

(show top 50) (show all 5161)
id Title Authors Year
1
The impact of liver disorders on perioperative management of reoperative cardiac surgery: a retrospective study in adult congenital heart disease patients. ( 28091794 )
2017
2
Assessment of coronary artery by prospective ECG-triggered 256 multi-slice CT on children with congenital heart disease. ( 28523472 )
2017
3
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease. ( 28070870 )
2017
4
Glutathione S-Transferase T1 (GSTT1) Null Polymorphism, Smoking, and Their Interaction in Coronary Heart Disease: A Comprehensive Meta-Analysis. ( 27686690 )
2017
5
The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China. ( 28067846 )
2017
6
Using Multimaterial 3-Dimensional PrintingA for Personalized Planning of Complex Structural Heart Disease Intervention. ( 28527767 )
2017
7
Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease. ( 27911047 )
2017
8
Reversal of angiographic findings of moyamoya syndrome after congenital cyanotic heart disease repair. ( 28084275 )
2017
9
Rheumatic Heart Disease: The Unfinished Global Agenda. ( 27886787 )
2017
10
Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease. ( 28091604 )
2017
11
Outcomes of borderline rheumatic heart disease: A prospective cohort study. ( 27883978 )
2017
12
Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. ( 28065906 )
2017
13
Tumor necrosis factor-alpha gene polymorphisms and susceptibility to ischemic heart disease: A systematic review and meta-analysis. ( 28383437 )
2017
14
The long-term risk of smoking in diabetic patients with stable ischemic heart disease treated with intensive medical therapy and lifestyle modification. ( 28517955 )
2017
15
Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. ( 28465308 )
2017
16
Utility and safety of the SafeSepta8c transseptal guidewire for electrophysiology studies with catheter ablation in pediatric and congenital heart disease. ( 28091832 )
2017
17
Lipoprotein-associated phospholipase A2, and subsequent cardiovascular events and mortality among patients with coronary heart disease. ( 27097870 )
2017
18
Characterization of soluble N-ethylmaleimide-sensitive factor attachment protein receptor gene STX18 variations for possible roles in congenital heart diseases. ( 27816473 )
2017
19
Should New Zealand introduce nationwide pulse oximetry screening for the detection of critical congenital heart disease in newborn infants? ( 28081558 )
2017
20
Cardiac haemangioma associated with a duct-dependent congenital heart disease in a newborn infant. ( 28077189 )
2017
21
Rheumatic heart disease in a developing country: Incidence and trend (Monastir; Tunisia: 2000-2013). ( 27883972 )
2017
22
Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study. ( 28052883 )
2017
23
Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients. ( 28067532 )
2017
24
A Post-operative Feeding Protocol to Improve Outcomes for Neonates With Critical Congenital Heart Disease. ( 28063770 )
2017
25
Mental Health Problems in Parents of Children with Congenital Heart Disease. ( 28534022 )
2017
26
Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation. ( 28061759 )
2017
27
Elevated ambulatory systolic-diastolic pressure regression index is genetically determined in hypertensive patients with coronary heart disease. ( 28092973 )
2017
28
Outcomes and Prognostic Factors for Adult Patients With Congenital Heart Disease Undergoing Primary or Reoperative Systemic Atrioventricular Valve Surgery. ( 28520541 )
2017
29
Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. ( 28534422 )
2017
30
Residents' understanding of adult congenital heart disease. ( 28092429 )
2017
31
Identification of Pulmonary Hypertension Caused by Left Heart Disease (World Health Organization Group 2) Based on Cardiac Chamber Volumes Derived from Chest CT. ( 28506612 )
2017
32
Critical Congenital Heart Disease Newborn Screening Implementation: Lessons Learned. ( 28092064 )
2017
33
The landscape of congenital heart disease. ( 28529923 )
2017
34
Timing and Mode of Delivery in Prenatally Diagnosed Congenital Heart Disease- an Analysis of Practices within the University of California Fetal Consortium (UCfC). ( 28078382 )
2017
35
High throughput in vivo functional validation of candidate congenital heart disease genes in Drosophila. ( 28084990 )
2017
36
Community-based prevalence study of rheumatic heart disease in rural Ethiopia. ( 28071960 )
2017
37
Decreased frequencies and impaired functions of the CD31(+) subpopulation in Treg cells associated with decreased FoxP3 expression and enhanced Treg cell defects in patients with coronary heart disease. ( 27997991 )
2017
38
Genotype Positive Long QT Syndrome in Patients With Coexisting Congenital Heart Disease. ( 28532774 )
2017
39
The effect of replacing saturated fat with mostly n-6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials. ( 28526025 )
2017
40
Quality of life: an underutilized patient-reported outcome for adults with congenital heart disease. ( 28523142 )
2017
41
Structural and congenital heart disease interventions: the role of three-dimensional printing. ( 28083857 )
2017
42
Acquired coronary artery disease in adult patients with congenital heart disease: a true or a false problem? ( 28072626 )
2017
43
HIV and Ischemic Heart Disease. ( 28057253 )
2017
44
Development of a Web-Based Health Care Intervention for Patients With Heart Disease: Lessons Learned From a Participatory Design Study. ( 28526674 )
2017
45
MiR-19b and miR-16 cooperatively signaling target the regulator ADRA1A in Hypertensive heart disease. ( 28531963 )
2017
46
Rheumatic heart disease in paediatric critical care retrieval. ( 28070958 )
2017
47
Resilience and personal growth: A potential resource for therapeutic programmes in people with congenital heart disease. ( 28071940 )
2017
48
Cardiac strain findings in children with latent rheumatic heart disease detected by echocardiographic screening. ( 28088920 )
2017
49
Clinical recommendations of cardiac magnetic resonance, Part II: inflammatory and congenital heart disease, cardiomyopathies and cardiac tumors: a position paper of the working group 'Applicazioni della Risonanza Magnetica' of the Italian Society of Cardiology. ( 28092290 )
2017
50
Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association. ( 28082385 )
2017